Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 5, 1996, Pages 443-448

  Al Yaman, Fadwa ^a   Genton, Blaise ^b   Kramer, Kenton J ^d   Chang, Sandra R ^c   Hui, George S ^c   Baisor, Moses ^b   Alpers, Michael P ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c UNIVERSITY OF HAWAII   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEMBRANE PROTEIN;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; DISEASE PREDISPOSITION; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOASSAY; INCIDENCE; INFANT; MALARIA; MEROZOITE; NORMAL HUMAN; PAPUA NEW GUINEA; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE;

EID: 0029900423     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.443     Document Type: Article

References (45)

1. McGregor IA, 1974. Mechanisms of acquired immunity and epidemiological patterns of antibody response in malaria in man. Bull World Health Organ 50: 259-266.
2. McGregor IA, 1987. Malarial immunity: current trends and prospects. Ann Trop Med Parasitol 81: 647-656.
3. Greenwood BM, Bradley AK, Greenwood AM, Byass P, Jammeh K, Marsh K, Tulloch S, Oldfield FS, Hayes R, 1987. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 81: 478-486.
4. Cattani JA, Moir JS, Gibson FD, Ginny M, Paino J, Davidson W, Alpers MP, 1986. Small-area variations in the epidemiology of malaria in Madang Province. PNG Med J 29: 11-17.
5. Cattani JA, Tulloch, JL, Vrbova H, Jolley D, Gibson FD, Moir JS, Heywood PF, Alpers MP, Stevenson AR, Clancy R, 1986. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. Am J Trop Med Hyg 35: 3-15.
6. Hall R, Hyde JE, Goman M, Simmons DL, Hope IA, Mackay M, Scaife J, Merkli B, Richle R, Stocker J, 1984. Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature 311: 379-382.
7. Patarroyo ME, Amador R, Clavijo P, Moreno A, Guzman F, Romero P, Tacson R, Franco A, Murillo LA, Ponton G, 1988. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 322: 158-161.
8. Perlmann P, Berzins K, Perlmann H, Troye-Blomberg M, Wahlgren M, Wahlin B, 1988. Malaria vaccine: immunogen selection and epitope mapping. Vaccine 6: 183-187.
9. Anders RF, Smythe JA, 1989. Polymorphic antigens in Plasmodium falciparum. Blood 74: 1865-1875.
10. Valero MV, Amador LR, Galindo C, Figueroa J, Bello MS, Murillo LA, Mora AI, Patarroyo G, Rocha CL, Rojas M, Aponte JJ, Sarmiento E, Lozada DM, Coronell CG, Ortega NM, Rosas JE, Alonso PL, Patarroyo ME, 1993. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341: 705-710.
11. Siddiqui WA, Tam LQ, Kramer KJ, Hui GS, Case SE, Yamaga KM, Chang SP, Chan EB, Kan SC, 1987. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci USA 84: 3014-3018.
12. Chang SP, Gibson HL, Lee NC, Barr PJ, Hui GS, 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibits parasite growth. J Immunol 149: 548-555.
13. Holder AA, 1988. The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy 41: 72-97.
14. Amador R, Moreno A, Valero V, Murillo L, Mora AL, Rojas M, Rocha C, Salcedo M, Guzman F, Espejo F, Nunez F, Patarroyo M, 1992. The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity. Vaccine 10: 179-184.
15. Gabra MS, Grossiord D, Perrin LH, Shaw A, Cheung A, McGregor LA, 1986. Defined Plasmodium falciparum antigens in malaria serology. Bull World Health Organ 64: 889-896.
16. Kramer KJ, Oberst R, 1992. Antibodies to the major merozoite surface coat protein in Plasmodium falciparum (gp195). in a human population living in a malaria-endemic area of the Philippines. Am J Trop Med Hyg 47: 429-439.
17. Riley EM, Morris-Jones S, Blackman MJ, Greenwood BM, Holder AA, 1993. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. Parasite Immunol 15: 513-524.
18. Riley EM, Alien SJ, Wheeler JG, Blackman MJ, Bennett S, Takacs B, Schonfeld HJ, Holder AA, Greenwood BM, 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP-1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 14: 321-337.
19. Tolle R, Fruch K, Doumbo O, Koita O, N'Diaye M, Fischer A, Dietz K, Bujard H, 1993. A prospective study of the association between the human humoral response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect Immun 61: 40-47.
20. Chizzolini C, Delaporte E, Kaufmann MH, Jakue JP, Verdini AS, Pessi A, del Giudice G, 1989. Age-related prevalence of antibody response against three different, defined Plasmodium falciparum antigens in children from the Haut-Ogooue province in Gabon. Trans R Soc Trop Med Hyg 83: 147-151.
21. Muller HM, Fruh K, von Brunn A, Esposito F, Lombardi S, Crisanti A, Bujard H, 1989. Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum. Infect Immun 57: 3765-3769.
22. Al-Yaman F, Genton B, Kenton K, Taraika J, Chang SP, Hui GS, Alpers MP, 1995. Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 (MSA-1) in residents of a highly endemic area of Papua New Guinea. Trans R Soc Trop Med Hyg 89: 555-559.
23. Genton B, Al-Yaman F, Beck HP, Hii J, Mellor S, Rare L, Ginny M, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province of Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann Trop Med Parasitol 89: 359-376.
24. Genton B, Al-Yaman F, Beck H-P, Hii J, Mellor S, Rare L, Ginny M, Smith T, Alpers MP, 1995. The epidemiology of malaria in the Wosera area, East Sepik Province of Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann Trop Med Parasitol 89: 377-390.
25. Genton B, Smith T, Baea K, Narara A, Al-Yaman F, Beck H-P, Hii J, Alpers MP, 1994. Malaria: how useful are clinical criteria for improving the diagnosis in a highly endemic area? Trans R Soc Trop Med Hyg 88: 537-541.
26. Chang SP, Kramer KJ, Yamaga KM, Kato A, Case SE, Siddiqui WA, 1988. Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda Palo Alto isolate. Exp Parasitol 67: 1-11.
27. Hui GS, Chang SP, Gibson H, Hashimoto A, Hashiro C, Barr PJ, Kotani S, 1991. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. J Immunol 147: 3935-3941.
28. Kramer KJ, Kan SC, Siddiqui WA, 1982. Concentration of Plasmodium falciparum-infected erythrocytes by density gradient centrifugation in Percoll. J Parasitol 68: 336-337.
29. SAS Institute Inc., 1989. SAS/STAT® user's Guide. Version 6, Fourth edition, Volume 2. Cary, NC: SAS Institute Inc.
30. Alpers MP, Al-Yaman F, Beck H-P, Bhatia KK, Hu J, Lewis DJ, Paru R, Smith TA, 1992. The malaria vaccine epidemiology and evaluation project of Papua New Guinea: rationale and baseline studies. PNG Med J 35: 285-297.
31. Al-Yaman F, Genton B, Anders R, Falk M, Triglia T, Lewis D, Hu J, Beck H-P, Alpers MP, 1994. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen 2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 51: 593-602.
32. Al-Yaman F, Genton B, Falk M, Anders R, Lewis D, Hii J, Beck H-P, Alpers MP, 1995. Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 52: 66-71.
33. Al-Yaman F, Genton B, Anders R, Taraika R, Chang SP, Hui GS, Alpers MP, 1995. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria. Parasite Immunol 17: 493-501.
34. Beck HP, Felger I, Kabintik S, Tavul L, Genton B, Alexander N, Bhatia KK, Al-Yaman F, Hii J, Alpers M, 1994. Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea. Am J Trop Med Hyg 51: 356-364.
35. Beck HP, Felger I, Genton B, Alexander N, Al-Yaman F, Anders RF, Alpers M, 1995. Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria. Infect Immun 63: 596-600.
36. Perrin LH, Merkli B, Loche M, Chizzolini C, Smart J, Richte R, 1984. Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages. J Exp Med 160: 441-451.
37. Cheung A, Leban J, Shaw AR, Merkli B, Stocker J, Chizzolini C, Sander C, Perrin LH, 1986. Immunization with synthetic peptides of Plasmodium falciparum surface antigen induces antimerozoite antibodies. Proc Natl Acad Sci USA 83: 8328-8332.
38. Patarroyo ME, Romero P, Torres ML, Clavijo P, Moreno A, Martinez A, Rodriguez R, Guzman F, Cabezas E, 1987. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature 328: 629-632.
39. Holder AA, Freeman RR, Nicholls SC, 1988. Immunisation against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol 10: 607-617.
40. Smith TA, Genton B, Baea K, Gibson N, Taime J, Narara A, Al-Yaman F, Beck H-P, Hii J, Alpers MP, 1994. Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area. Parasitology 109: 539-549.
41. Miller LH, Roberts T, Shahabuddin M, McCutchan TE, 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol 59: 1-14.
42. Etlinger HM, Caspers P, Matile H, Schoenfeld JH, Stueber D, Takacs B, 1991. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun 59: 3498-3503.
43. Chang SP, Hui GS, Kato A, Siddiqui WA, 1989. Generalized immunoiogical recognition of the major merozoite surface antigen (gp 195) of Plasmodium falciparum. Proc Natl Acad Sci USA 86: 6343-6347.
44. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA, 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med 172: 379-382.
45. Burns JM, Parke LA, Daly TM, Cavacini LA, Weidanz WP, Long CA, 1989. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J Immunol 142: 2835-2840.